AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Momotaro-Gene Inc.
  3. Financials
  4. Total current liabilities

Momotaro-Gene Inc.【JP:E33052】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndTotal current liabilities (Million JPY)YoY (%)
Mar 31, 2023279+536.48%
Mar 31, 202244-28.10%
Mar 31, 202161-10.56%
Mar 31, 202068+17.89%
Mar 31, 201958+63.83%
Mar 31, 201835-67.36%
Mar 31, 2017108+54.90%
Mar 31, 201670+14.96%
Mar 31, 201561+655.01%
Mar 31, 20148+29.55%
Mar 31, 20136+32.88%
Mar 31, 20125+26.73%
Mar 31, 20114-60.06%
Mar 31, 20109-84.35%
Mar 31, 200959

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)